Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-076916

Chief Operating Officer sold 3,366 shares at $56.09 ($188,799)

  • Chief Operating Officer acquired 7,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bruno Julianne Chief Operating Officer 2024-06-20 Option exercise +7,000 10,111 D
Bruno Julianne Chief Operating Officer 2024-06-21 Sale −3,366 $56.09 $188,799 6,745 D
Derivatives
Bruno Julianne Chief Operating Officer 2024-06-20 Option exercise · Restricted Stock Units −7,000 0 D
Open-market sales · 3,366 sh · avg $56.09 · $188,799
Loading xslF345X05/ownership.xml…